This week’s round-up includes the discovery of a novel method for mass spectometry and thermal desorption, as well as an update from Waters Corp (MA, USA) on their aquisition of DESI technology exclusive rights.
Read time: 1 min
Researchers from the Sackler School of Medicine at Tel Aviv University (Israel) have identified novel RNA biomarkers for preeclampsia.
Researchers from Wayne State University School of Medicine (MI, USA) have indicated that RNA from sperm could be a promising determinant for a successful live birth and an indicator for the health of the child as they mature.
In this article Johannes Winkler discusses how the recent clinical successes prove that synthetic oligonucleotides are useful therapeutic agents and outlines some obstacles that need to be overcome for a more widespread and safe application.
Researchers explored the potential use of long non-coding RNAs as diagnostic and prognostic biomarkers for patients with urothelial carcinoma.
Handheld device that could allow Ebola diagnosis in remote locations is proven to be reliable and quick to use
On-the-spot diagnosis for certain cancers and other disease brought closer to reality due to new sensitive biosensor.
Researchers have successfully used matrix-assisted laser desorption ionization mass spectrometry to analyze a mixture of intact virus particles.
Four microRNA biomarkers identified to help in the differential diagnosis between malignant pleural mesothelioma and noncancerous pleural tissue with reactive mesothelial proliferations.
The team found that they could monitor health and development of specific tissues by analyzing RNA molecules encoding tissue-specific proteins.